Healthcare related costs associated with donepezil use in patients with very mild dementia due to Alzheimer's disease: A retrospective observational study
Although Donepezil users initially had lower healthcare costs, overall healthcare drug costs increased in the Donepezil group at both the 1-year and 3-year follow-ups, while inpatient drug costs were only reduced in the short term.
Authors
- Sun‐Wung Hsieh (ORCID: https://orcid.org/0000-0003-3952-7718)
- Hui‐Min Hsieh (ORCID: https://orcid.org/0000-0003-3286-7306)
- Yuan‐Han Yang (ORCID: https://orcid.org/0000-0002-1918-9021)
- Chen‐Yang Hsiao (ORCID: https://orcid.org/0009-0008-3224-9552)
Institutions
- Kaohsiung Medical University (TW)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
- Kaohsiung Municipal Hsiao-Kang Hospital (TW)
Publication Details
- Journal
- Journal of Alzheimer s Disease Reports
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1177/25424823251356233
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00